OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases
Maxime Taquet, Masud Husain, John Geddes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Ann R. Falsey, Magdalena E. Sobieszczyk, Ian Hirsch, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 25, pp. 2348-2360
Open Access | Times Cited: 384

Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis
John G. Rizk, Aashish Gupta, Partha Sardar, et al.
JAMA Cardiology (2021) Vol. 6, Iss. 12, pp. 1451-1451
Open Access | Times Cited: 101

Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency
Katarzyna Krzywicka, Mirjam R. Heldner, Mayte Sánchez van Kammen, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 11, pp. 3656-3662
Open Access | Times Cited: 95

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
Pedro M. Folegatti, Daniel Jenkin, Susan Morris, et al.
Vaccine (2022) Vol. 40, Iss. 35, pp. 5248-5262
Open Access | Times Cited: 31

Vaccine‐induced immune thrombotic thrombocytopenia after vaccination against Covid‐19: A clinical dilemma for clinicians and patients
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 40

An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations
Amin Islam, Mohammed Sheraz Bashir, Kevin Joyce, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 5004-5004
Open Access | Times Cited: 40

Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines
Jasmine Shimin Koh, Rebecca Hui Min Hoe, Ming Hui Yong, et al.
Journal of the Neurological Sciences (2021) Vol. 430, pp. 120030-120030
Open Access | Times Cited: 34

A reasoned approach towards administering COVID‐19 vaccines to pregnant women
Angsumita Pramanick, Abhiram Kanneganti, Jing Lin Jeslyn Wong, et al.
Prenatal Diagnosis (2021) Vol. 41, Iss. 8, pp. 1018-1035
Open Access | Times Cited: 16

Vaccines against Covid-19, venous thromboembolism, and thrombocytopenia. A population-based retrospective cohort study
Joan‐Ramon Laporte, Ermengol Coma, Francesc Fina, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8

ДЕРЖАВНЕ РЕГУЛЮВАННЯ ЯК ЧИННИК ПРОТИДІЇ COVID-19
Sergiy Korablin
Economy of Ukraine (2021) Vol. 64, Iss. 7 (716), pp. 27-40
Open Access | Times Cited: 8

Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
Muhammad Imran Ahmad Qureshi, Bilal Azam, Muhammad Aamir Waheed, et al.
BMJ Case Reports (2022) Vol. 15, Iss. 5, pp. e247493-e247493
Open Access | Times Cited: 6

Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations
Michael Laffan, Sue Rees, Madhavi Yadavalli, et al.
Vaccine (2022) Vol. 40, Iss. 38, pp. 5585-5593
Open Access | Times Cited: 6

Thrombosis and thromboembolism: Brighton collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Jahnavi Gollamudi, Sarah E. Sartain, Amir Navaei, et al.
Vaccine (2022) Vol. 40, Iss. 44, pp. 6431-6444
Open Access | Times Cited: 6

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
James L. Alexander, Nick Powell
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 7, pp. 528-529
Open Access | Times Cited: 7

The effectiveness and safety of the use of antithrombotic therapy in COVID-19
Kirill Lobastov, O. Ya. Porembskay, Ilya Schastlivtsev
Ambulatornaya khirurgiya = Ambulatory Surgery (Russia) (2021) Vol. 18, Iss. 2, pp. 17-30
Open Access | Times Cited: 6

Sensitivity to Moral Principles Predicts Both Deontological and Utilitarian Response Tendencies in Sacrificial Dilemmas
Dries H. Bostyn, Arne Roets, Paul Conway
Social Psychological and Personality Science (2021) Vol. 13, Iss. 2, pp. 436-445
Open Access | Times Cited: 5

Neuropsychiatric disorders and COVID-19 – Authors' reply
Maxime Taquet, John Geddes, Masud Husain, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 7, pp. 565-566
Open Access | Times Cited: 4

Orofacial adverse effects of COVID-19 vaccines exist but are rare
Ahmad Sofi‐Mahmudi
Evidence-Based Dentistry (2021) Vol. 22, Iss. 2, pp. 70-71
Open Access | Times Cited: 3

Blood Clotting Decreases Pulmonary Circulation during the Coronavirus Disease
Anastasia Mozokhina, Anass Bouchnita, Vitaly Volpert
Mathematics (2021) Vol. 9, Iss. 19, pp. 2401-2401
Open Access | Times Cited: 3

Neurologische Nebenwirkungen der COVID-19-Impfung
Hans-Christoph Diener, Peter Berlit, Christian Gerloff, et al.
InFo Neurologie + Psychiatrie (2022) Vol. 24, Iss. 1, pp. 32-43
Closed Access | Times Cited: 2

Zerebrale Venenthrombosen im Zeitalter der COVID-19-Pandemie
Frank Stachulski
CardioVasc (2021) Vol. 21, Iss. 5, pp. 34-38
Closed Access | Times Cited: 2

Battlefield Medicine
Benjamin Davido
Inference International Review of Science (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top